FORTE BIOSCIENCES, INC. Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount
FORTE BIOSCIENCES, INC. (FBRX) reported Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount of $14.59 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance · last filed 2026-03-31
- FORTE BIOSCIENCES, INC. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2025 was $14.59M, a 126.47% increase from fiscal 2024.
- FORTE BIOSCIENCES, INC. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2024 was $6.44M, a 1.53% decline from fiscal 2023.
- FORTE BIOSCIENCES, INC. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2023 was $6.54M, a 148.90% increase from fiscal 2022.
- FORTE BIOSCIENCES, INC. effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount for fiscal 2022 was $2.63M, a 30.97% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount 12 month |
|---|---|
| 2025-12-31 | $14.59M 10-K · filed 2026-03-31 |
| 2024-12-31 | $6.44M 10-K · filed 2026-03-31 |
| 2023-12-31 | $6.54M 10-K · filed 2025-03-28 |
| 2022-12-31 | $2.63M 10-K · filed 2024-03-18 |
| 2021-12-31 | $3.81M 10-K · filed 2023-03-31 |
| 2020-12-31 | $4.39M 10-K · filed 2022-03-31 |
| 2019-12-31 | $1.15M 10-K · filed 2021-03-16 |